Fidelity Select Pharmaceuticals FPHAX
14195 views
Rate Now:
average rating: 4.00 / 1 ratings
DESCRIPTION:
Date updated:10-16-2007
This fund has a Morningstar rating of 3 stars and is run by Andrew Oh. Oh is manager of Pharmaceuticals Portfolio, which he has managed since July 2006. He joined Fidelity Investments in 2006 as an equity research analyst. Prior to Fidelity, Oh was director and senior pharmaceuticals analyst for Leernik Swann & Company in New York. From 2001 to 2004, he was senior equity research associate following the U.S. large cap pharmaceuticals sector for JP Morgan Chase in New York. Fidelity Select Pharmaceuticals Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types.
Current Returns:
1-Year: 13.69%
3-Year: 16.64%
5-Year: 12.12%
-
MRK
Merck & Company - $37.16
- +0.76%
- $37.05
No Analysis added
-
SGP
Schering Plough C - $28.15
- 0.00%
- $N/A
No Analysis added
-
BMY
Bristol-myers Squ - $25.89
- -0.27%
- $25.88
No Analysis added
-
WYE
Wyeth - $50.39
- 0.00%
- $N/A
No Analysis added
-
ABT
Abbott Laboratori - $54.52
- -1.84%
- $55.04
No Analysis added
-
JNJ
Johnson & Johnson - $64.18
- -0.06%
- $64.26
No Analysis added
-
LLY
Eli Lilly And Com - $35.93
- +0.31%
- $35.99
No Analysis added
-
PFE
Pfizer - $17.08
- -1.21%
- $17.19
No Analysis added
- No Blogs Found
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Fidelity Select Pharma...
- 3. Calamos Advisors
- 4. ProFunds Pharmaceutica...
- 5. BlackRock Health Scien...
- show all
- Top Do-It-Yourself Portfolios
- » jgroov Portfolio 1
- » ben johnson
- » my holdings
- » SC TRADE OF THE DAY
- » kudos
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
Rocket Stocks for the Week
By Jonas Elmerraji Posted on March 15, 2010, at 8 a.m. EDT Financial reform should be this week’s biggest buzzword as details of Capitol Hill’s latest plans start t...
03.15.10 | 08:02 AM
Dividend-Boosting Stocks: Wal-Mart
By Jonas Elmerraji Posted on March 12, 2010 Dividend-paying companies took a mini-break from hiking their payouts to shareholders last week. Only 14 companies announced...
03.12.10 | 14:15 PM
Jim Cramer's Portfolios of the Week
By Roberto Pedone Posted on March 12, 2010 According to Jim Cramer, the stock market is trading higher for some very good reasons! In a March 11 RealMoney.com blog pos...
03.12.10 | 08:40 AM
Must-See Charts: Bank of America...
more articles
By Jonas Elmerraji Posted on March 11, 2010 The S&P 500 refuses to back down from its rally after posting gains in eight of the last 10 trading days. That’s a colossa...
03.11.10 | 10:37 AM
What is happening to SBAC?
03.15.10 | 10:20 AM From author
Danee
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author
Trading Nymph
The Presidential/Political Thread
01.02.08 | 08:05 AM From author
Dave Cox
Cartoon Thread
more forums
11.15.07 | 20:31 PM From author
Peter near Matanzas Inlet
Q.
Hello,
do you have any opinion ...
03.15.10 | 10:28 AM Asked by
emcsull
A. Hi Ellen, I have not heard of Ormal but
whenever you have reservations about a
company, don't get in. There are so
many good company to put your money to
work.
Q.
Steel....playing catch up now. ...
03.24.09 | 11:34 AM Asked by
dgbkr
A. The only one I own : SLX,
too hard pick a winner out all of them
today 's lists
TheStreet Ratings' Downgrades
TheStreet Ratings provides exclusive stock, ETF and mutual fund ratings and commentary based on award-winning, proprietary tools. Its safety first approach to investing aim... more
Rising on Unusual Volume
Here are some stocks that moved up on unusual volume on Mar. 12, 2010. more
Top Open-Market Insider Buys
Below is the list of the top open-market insider buys filed at the SEC on Mar. 12, 2010. more
Comments not available